These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1531362)

  • 1. 5-HT2 receptor antagonists reverse amphetamine-induced slowing of dopaminergic neurons by interfering with stimulated dopamine synthesis.
    Sorensen SM; Humphreys TM; Taylor VL; Schmidt CJ
    J Pharmacol Exp Ther; 1992 Feb; 260(2):872-8. PubMed ID: 1531362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ritanserin, a 5-HT2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition.
    Ugedo L; Grenhoff J; Svensson TH
    Psychopharmacology (Berl); 1989; 98(1):45-50. PubMed ID: 2524859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 5-HT2 receptor antagonist, MDL 28,133A, disrupts the serotonergic-dopaminergic interaction mediating the neurochemical effects of 3,4-methylenedioxymethamphetamine.
    Schmidt CJ; Black CK; Taylor VL; Fadayel GM; Humphreys TM; Nieduzak TR; Sorensen SM
    Eur J Pharmacol; 1992 Sep; 220(2-3):151-9. PubMed ID: 1425989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chloral hydrate anesthesia alters the responsiveness of identified midbrain dopamine neurons to dopamine agonist administration.
    Kelland MD; Freeman AS; Chiodo LA
    Synapse; 1989; 3(1):30-7. PubMed ID: 2919369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of midbrain presumed dopaminergic neurones by muscarinic cholinergic receptors: an in vivo electrophysiological study in the rat.
    Gronier B; Rasmussen K
    Br J Pharmacol; 1998 Jun; 124(3):455-64. PubMed ID: 9647468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-HT2 antagonists stereoselectively prevent the neurotoxicity of 3,4-methylenedioxymethamphetamine by blocking the acute stimulation of dopamine synthesis: reversal by L-dopa.
    Schmidt CJ; Taylor VL; Abbate GM; Nieduzak TR
    J Pharmacol Exp Ther; 1991 Jan; 256(1):230-5. PubMed ID: 1899117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective 5-hydroxytryptamine2 receptor antagonists protect against the neurotoxicity of methylenedioxymethamphetamine in rats.
    Schmidt CJ; Abbate GM; Black CK; Taylor VL
    J Pharmacol Exp Ther; 1990 Nov; 255(2):478-83. PubMed ID: 1978728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophysiological and pharmacological characteristics of nigral dopaminergic neurons in the conscious, head-restrained rat.
    Fà M; Mereu G; Ghiglieri V; Meloni A; Salis P; Gessa GL
    Synapse; 2003 Apr; 48(1):1-9. PubMed ID: 12557266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the 5-HT2 receptor in the methamphetamine-induced neurochemical alterations.
    Johnson M; Sonsalla PK; Letter AA; Hanson GR; Gibb JW
    J Pharmacol Exp Ther; 1994 Jul; 270(1):97-103. PubMed ID: 7913500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-HT3 receptor activation is required for induction of striatal c-Fos and phosphorylation of ATF-1 by amphetamine.
    Genova LM; Hyman SE
    Synapse; 1998 Sep; 30(1):71-8. PubMed ID: 9704883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-HT2 receptors differentially modulate dopamine-mediated auto-inhibition in A9 and A10 midbrain areas of the rat.
    Olijslagers JE; Werkman TR; McCreary AC; Siarey R; Kruse CG; Wadman WJ
    Neuropharmacology; 2004 Mar; 46(4):504-10. PubMed ID: 14975674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of cocaine on firing rate and pattern of dopamine neurons: role of alpha1 receptors and comparison with L-dopa and apomorphine.
    Zhou Y; Bunney BS; Shi WX
    J Pharmacol Exp Ther; 2006 Apr; 317(1):196-201. PubMed ID: 16330495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of 5-HT(2A) receptor antagonism in amphetamine-induced inhibition of A10 dopamine neurons in vitro.
    Olijslagers JE; Perlstein B; Werkman TR; McCreary AC; Siarey R; Kruse CG; Wadman WJ
    Eur J Pharmacol; 2005 Sep; 520(1-3):77-85. PubMed ID: 16154561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional interaction between serotonin-S2 and dopamine-D2 neurotransmission as revealed by selective antagonism of hyper-reactivity to tryptamine and apomorphine.
    Awouters F; Niemegeers CJ; Megens AA; Janssen PA
    J Pharmacol Exp Ther; 1990 Sep; 254(3):945-51. PubMed ID: 1697623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CI-943, a potential antipsychotic agent. III. Evaluation of effects on dopamine neuronal activity.
    Meltzer LT; Christoffersen CL; Heffner TG; Freeman AS; Chiodo LA
    J Pharmacol Exp Ther; 1989 Oct; 251(1):123-30. PubMed ID: 2571714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute and chronic administration of the selective 5-HT1A receptor antagonist WAY-405 significantly alters the activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study.
    Minabe Y; Schechter L; Hashimoto K; Shirayama Y; Ashby CR
    Synapse; 2003 Dec; 50(3):181-90. PubMed ID: 14515335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo extracellular recording of striatal neurons in the awake rat following unilateral 6-hydroxydopamine lesions.
    Chen MT; Morales M; Woodward DJ; Hoffer BJ; Janak PH
    Exp Neurol; 2001 Sep; 171(1):72-83. PubMed ID: 11520122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subthalamic nucleus lesions alter basal and dopamine agonist stimulated electrophysiological output from the rat basal ganglia.
    Zahr NM; Martin LP; Waszczak BL
    Synapse; 2004 Nov; 54(2):119-28. PubMed ID: 15352137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-unit responses of serotonergic dorsal raphe neurons to 5-HT1A agonist and antagonist drug administration in behaving cats.
    Fornal CA; Litto WJ; Metzler CW; Marrosu F; Tada K; Jacobs BL
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1345-58. PubMed ID: 7932189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopaminergic activation excites rat lateral habenular neurons in vivo.
    Kowski AB; Veh RW; Weiss T
    Neuroscience; 2009 Jul; 161(4):1154-65. PubMed ID: 19374940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.